CompletedPhase 3NCT00596271

Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440

Studying Encephalitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Valneva Austria GmbH
Principal Investigator
Astrid Kaltenboeck, Ph.D.
Valneva Austria GmbH
Intervention
IC51(biological)
Enrollment
192 enrolled
Eligibility
18 years · All sexes
Timeline
20052008

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00596271 on ClinicalTrials.gov

Other trials for Encephalitis

Additional recruiting or active studies for the same condition.

See all trials for Encephalitis

← Back to all trials